Cover Image
市場調查報告書

人工淚液的全球市場

Artificial Tears

出版商 Global Industry Analysts, Inc. 商品編碼 248932
出版日期 內容資訊 英文 221 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
人工淚液的全球市場 Artificial Tears
出版日期: 2016年02月01日 內容資訊: 英文 221 Pages
簡介

本報告涵括人工淚液的全球市場,提供美國,加拿大,日本,歐洲,亞太地區,南美及其他地區等地區別個別分析,以及過去的實際成果/估計和未來預測,並彙整28家主要企業及利基企業的公司簡介等資料,為您概述為以下內容。

第1章 簡介,調查方法,產品定義

  • 調查的可靠性和報告的限制
  • 免責聲明
  • 資料的解釋和報告的水準
    • 定量技術及分析法
  • 產品的定義和調查範圍

第2章 摘要整理

  • 產業概要
    • 產業動態
    • 店面銷售(OTC)製劑
    • 乾眼症:報告少,未適當治療的症狀
    • 現在及未來分析
    • 富有機會的開發中國家
    • 缺乏明確的產品差異化造成混亂
  • 主要的關注議題與趨勢
    • 高齡化的人口和女性是主要的客戶
    • 電腦及隱形眼鏡的利用增加促進市場成長
    • 困難的製劑
    • 低專利限制了市場機會
    • 穩定需求的OTC產品
    • 不使用防腐劑的人工淚液輩受好評
    • 處方乾眼症產品市場:集中度高
    • 直銷促銷:重要的行銷策略
  • 眼科用藥市場:概要
    • 眼科疾病
    • 主要的眼科疾病症狀
    • 主要的眼科產品
    • 眼科的產業機會:主要的暗示
    • 新藥及技術開發氣勢仍高
    • 專利到期的眼科用藥市場將成為成長的課題
    • 產品的創新大有助於患者
    • 醫療費給付:在商業性成功中相當重要
    • 展望眼科用藥的未來
  • 乾眼症症候群:產業動態
    • 乾眼症的多因素性成為對製藥公司而言的挑戰
    • 成為乾眼症症候群的診斷和治療之間的橋樑
    • 為乾眼症治療帶來變革的新配合措施
    • 抗發炎藥
    • 粘蛋白分泌催化劑
    • 荷爾蒙療法
    • Omega-3藥
    • 粘性劑(Muco-Mimetics)
    • Barrier-function Drugs
      • 乾眼症治療的開發平台藥物候補
  • 產品概要
  • 產品的發表/創新
  • 產業的最近的動向
  • 主要的國際企業
    • Abbott Medical Optics, Inc.(美國)
    • Allergan, Inc.(美國)
    • Advanced Vision Research, Inc(美國)
    • Bausch & Lomb(美國)
    • McNEIL-PPC, Inc(美國)
    • Novartis International AG(瑞士)
    • Alcon, Inc.(瑞士)
    • 參天製藥(日本)
    • Novagali Pharma S.A.(法國)
  • 全球市場的展望

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 其他歐洲
  • 亞太地區
  • 南美
  • 其他地區

第4章 競爭情形

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7743

This report analyzes the worldwide markets for Artificial Tears in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 68 companies including many key and niche players such as -

Abbott Medical Optics Inc.
Allergan, Inc.
Akorn, Inc.
Bausch & Lomb Incorporated
Johnson & Johnson

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Dry Eyes - An Emerging Lucrative Segment of Ophthalmology Market
    • Table 1: Global Ophthalmology Market (2015): Percentage Share Breakdown by Product Segment (includes corresponding Graph/Chart)
  • Artificial Tears: The First Line of Treatment for Dry Eyes
  • Current & Future Analysis
  • Developing Countries Display Untapped Potential
  • Under-reporting of DES Condition Stifles Market Opportunities
  • Prevalence and Incidence of Dry Eye Syndrome
    • Table 2: Prevalence of Dry Eye Syndrome Across Select Countries (in %) (includes corresponding Graph/Chart)
  • Select Stats on Prevalence Rates
  • Concentrated Prescription Dry Eye Products Market Benefits OTC Market
  • Aging Population - A Major Growth Driver
    • Table 3: Global Population Demographics (2014 & 2020P): Percentage Breakdown of Population by Age Group - Below 40 Years and 40 Years & Above (includes corresponding Graph/Chart)
    • Table 4: Global Population Statistics for 65+ Age Group (2014) (includes corresponding Graph/Chart)
  • Market Challenges
  • Lack of Clear Product Differentiation Leads to Confusion
  • Drug Formulation Fraught with Difficulties
  • Low Patient Compliance Limits Market Opportunities

2. NOTEWORTHY MARKET TRENDS

  • Preference for Preservative-Free Artificial Tears on Rise
  • Ongoing Technology Evolution Boosts Growth
  • Artificial Tears for Dry Eye Syndrome-Single-use (Unit dose)
  • Artificial Tears for Dry Eye Syndrome -Multi dose
  • Management of Dry Eyes Post Eye Surgery Drives Demand
  • Growth in Mobile Workforce and Number of Smartphone Addicts Augurs Well for Market Growth
  • Rise in Contact Lens Wearers - Another Opportunity Market
    • Table 5: Penetration of Contact Lenses in Select Countries/Regions (2013) (includes corresponding Graph/Chart)
  • Focus Grows on Formulating the Right Artificial Tears for Contact Lens Wearers
  • Environmental Factors - Playing an Important Role
  • Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment
  • Direct-to-Customer Promotions: A Primary Marketing Strategy

3. DRY EYE SYNDROME - INDUSTRY DYNAMICS

  • Multi-Factorial Nature of Dry Eye Poses Challenges to Drug Makers
  • Bridging Chasm between Diagnosis and Treatment of Dry Eye Syndrome
  • Competition
  • Leading Drugs in the Pipeline
  • Shire Plc Eyes FDA Re-submission after Positive Phase III Results of Lifitegrast
  • First Patients Enrolled in Phase2b/3 of RegeneRx's RGN-259
  • Mimetogen's MIM-D3 Promises Huge Potential
  • Clouds of Uncertainty Looms over Santen's Ikervis
  • Herantis Pharma Kick Starts Phase 2 Study of Cis-UCA Eye Drops
  • Mitotech's SkQ1 Displays Positive Results
  • Novaliq's CyclASol Enters Phase II Development Stage
    • Drugs in the Late-Stage Pipeline for Dry Eye Treatment (2015)
  • Other Promising Solutions in the Artificial Tear Market
  • Retaine MGD
  • Rebagen
  • Tofacitinib
  • Positive Effects of Autologous Serum Eyedrops
  • Resolvins - Capturing Fancy
  • Oculeve to Continue Testing
  • IL-1 Gains Prominence
  • Role of Steroids in DES Treatment
  • Carbomer-Based Artificial Tear Formulations
  • Androgen and Estrogen Receptor Inhibitors

4. PRODUCT OVERVIEW

  • Dry Eye - A Common Ophthalmic Condition
  • Causes of Dry Eyes
  • Diagnosis of Dry Eye Syndrome
  • Treatment Strategies
  • Artificial Tears - A Brief Overview
  • Product Options for Dry Eye Syndrome: Breakdown by Palliative Therapies and Targeted Therapies
  • KCS Inflammation Cycle
  • Common Symptoms of KCS
  • Risk Factors for Dry Eye Disease
  • Impact of Dry Eye Syndrome on Routine Daily Life Activities: Ranking based on Intensity of Impact Felt by Patients
  • Types of Artificial Tears
  • Artificial Tears Usage and Dosage
  • Drug Contraindications or Interactions
  • Osmolarity
    • Table 6: Osmolarity of Select Ocular Brands (includes corresponding Graph/Chart)
  • Alternate Treatment Methods
  • Evolution of Artificial Tears
  • First-Generation
  • Second-Generation
  • Third-Generation
  • Fourth-Generation
  • Novel Approaches to Revolutionize Dry Eye Therapy
  • Anti-Inflammatory Drugs
  • Mucin Secretagogues
  • Hormonal Therapies
  • Omega-3 Drugs
  • Muco-Mimetics
  • Barrier-function Drugs

5. PRODUCT LAUNCHES/APPROVALS/ INTRODUCTIONS

  • Allergan Submits PAS for RESTASIS MDPF
  • NICE Issues FAD Recommending Santen's IKERVIS for Severe Keratitis
  • Allergan plc Launches REFRESH OPTIVE Gel Drops
  • URSAPHARM Collaborates with Novaliq and Launches EvoTears
  • Shire plc Announces FDA's Priority Review Designation for Lifitegrast
  • Avizorex Pharma Receives Patent for AVX-102
  • SilkTears Develops HXP-27 Protein for Tear Formulations
  • Bausch & Lomb Launches Soothe(r) Xtra Protection (XP) Eye Drops
  • Santen Europe Launches Ocutears(r) in Bulgaria
  • Similasan Introduces Similasan Complete Eye Relief
  • Nicox S.A. Announces European Launch of Xailin(tm)
  • DiagnosTear Receives Approvals to Start Clinical Study with TeaRx
  • Neuroptis Bitoech Announces Positive Preclinical Trial Results of ML7 Eye Drops
  • Santen Pharmaceuticals Launches OTC Eye Drops Soft Santear
  • Bausch & Lomb Acquires License for Mimetogen's MIM-D3
  • Candorvision Launches Hylo(tm) for Dry Eye Disease

6. RECENT INDUSTRY ACTIVITY

  • Allergan and Pfizer Enter Into Merger Agreement
  • Allergan Enters into Licensing Agreement with Mimetogen for Tavilermide
  • Shire Acquires Foresight Biotherapeutics
  • BioLight Life Sciences Enters Into Collaboration Agreement with Ora, Inc.
  • Collaboration between Valeant and Croma to Expand Bausch + Lomb's Portfolio
  • NovaMedica and SIFI Enter Into Marketing Agreement
  • NicOx S.A. Acquires Eupharmed Srl

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Medical Optics Inc. (US)
  • Allergan, Inc. (US)
  • Akorn, Inc. (US)
  • Bausch & Lomb Incorporated. (US)
  • Johnson & Johnson (US)
  • Novartis International AG (Switzerland)
  • Alcon, Inc. (Switzerland)
  • Santen Pharmaceuticals Co, Ltd. (Japan)
  • Novagali Pharma S.A. (France)

8. GLOBAL MARKET PERSPECTIVE

    • Table 7: World Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Artificial Tears by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
    • Table 9: World 14-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • Table 10: Prevalence of Dry Eye in the United States for the Years 2006, 2009, 2012, & 2015 (In Millions of Individuals) (includes corresponding Graph/Chart)
    • Table 11: Number of Individuals Treated for Dry Eye in the United States (In 000s) for the Years 2006, 2009 & 2012 (includes corresponding Graph/Chart)
    • Demographics Remain an Important Growth Driver
    • Table 12: US Population Demographics (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
    • Table 13: Prevalence of Dry Eye Condition in the US (2014) (includes corresponding Graph/Chart)
    • Table 14: US Women Population (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
    • Eye Care Market Thrives Due to Lifestyle and Environmental Factors
    • Air Pollution Bears Close Association with DES Risk
    • Thriving OTC Market Offers Good Potential for Artificial Tears
    • Restasis- The Leading Drug for Dry Eyes
    • Product Launches
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 15: US Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 16: US Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
  • B. Market Analytics
    • Table 17: Canadian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 18: Canadian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Eye Care Products Targeting Specific Consumer Segments Drive the Market
    • Table 19: Japanese Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Rohto Pharmaceutical, and Others (includes corresponding Graph/Chart)
    • Product Launch
    • Select Players
  • B. Market Analytics
    • Table 20: Japanese Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 21: Japanese Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Ophthalmic Pharmaceutical Drugs Market in Europe
    • Artificial Tears Reimbursement Overview
  • B. Market Analytics
    • Table 22: European Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 23: European Historic Review for Artificial Tears by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
    • Table 24: European 14-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • High Pollen Count Boosts Eye Care Market
    • Table 25: French Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Johnson & Johnson Sante Beaute, Laboratoires Pierre Fabre, and Others (includes corresponding Graph/Chart)
    • Product Launches
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 26: French Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 27: French Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Digitalised Lifestyle Promotes Eye Care Market
    • Table 28: German Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Gerhard Mann Chem-Pharm Fabrik, and Others (includes corresponding Graph/Chart)
    • Product Launch
  • B. Market Analytics
    • Table 29: German Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 30: German Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current and Future Analysis
    • Dry Eye Syndrome Drives Eye Care Product Market
  • B. Market Analytics
    • Table 31: Italian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 32: Italian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • High Smartphones' and Tablets' Usage Drive Eye Care Product Market
    • Product Launch
    • Strategic Corporate Development
    • Spectrum Thea Pharmaceuticals Limited - A UK Key Player
  • B. Market Analytics
    • Table 33: UK Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 34: UK Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
  • B. Market Analytics
    • Table 35: Spanish Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 36: Spanish Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current and Future Analysis
    • Cost-Minded Consumers Restrain the Market
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 37: Russian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 38: Russian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launches
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 39: Rest of Europe Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 40: Rest of Europe Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Opportunities Abound for Indian OTC Market
  • B. Market Analytics
    • Table 41: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - China, India, and Rest of Asia Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 42: Asia-Pacific Historic Review for Artificial Tears by Geographic Region - China, India, and Rest of Asia Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
    • Table 43: Asia-Pacific 14-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Current and Future Analysis
    • Modern Lifestyle Trends Boost Eye Care Product Market
    • Table 44: Chinese Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Mentholatum (Zhongshan) Pharmaceuticals Co. Ltd., and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 45: Chinese Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 46: Chinese Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Current and Future Analysis
    • Prescription-Based Products Dominate the Market
    • Table 47: Indian Eye Care Market by leading Player (2015): Percentage Share Breakdown of Revenues for Allergan India, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 48: Indian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 49: Indian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 50: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 51: Rest of Asia-Pacific Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
    • Alcon: The Clear Market Leader in Brazilian Eye Care Market
    • Table 52: Brazilian Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Alcon Laboratorios do Brasil, and Others (includes corresponding Graph/Chart)
    • Mexico - Restrained by Inadequate Diagnosis
    • Table 53: Mexican Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Alcon Laboratorios, Laboratorios Sophia, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 54: Latin American Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 55: Latin American Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 56: Rest of World Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
    • Table 57: Rest of World Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top